Indication
SCN2A-DEE
1 clinical trial
1 product
Product
PRAX-222Clinical trial
A Seamless, Clinical Trial to Investigate the Safety and Efficacy of Multiple Doses of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic EncephalopathyStatus: Active (not recruiting), Estimated PCD: 2025-07-01